JordanBerlinMD

Oncology • Nashville, TN

Gastrointestinal Cancer

Professor, Medicine, Vanderbilt University School of Medicine

Join to view full profile

Dr. Berlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Berlin's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Summary

Board certified in medical oncology

Education & Training

University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1992 - 1995
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1989 - 1992
University of Illinois College of MedicineClass of 1989

Certifications & Licensure

TN State Medical License 1999 - 2025
AL State Medical License 2020 - 2020
IL State Medical License 1995 - 1999
WI State Medical License 1992 - 1999
OH State Medical License 1991 - 1992
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow, American Society of Clinical ONcology ASCO, 2019

Clinical Trials

Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer Start of enrollment: 2017 Aug 23
Active, not recruiting
Phase 1, Phase 2
Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery Start of enrollment: 2005 May 01
Completed
Phase 2
Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer Start of enrollment: 2011 Jun 01
Terminated
Phase 2
Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery Start of enrollment: 2008 Oct 01
Completed
Phase 2
Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies Start of enrollment: 2016 Nov 01
Terminated
Phase 1, Phase 2
Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2015 Apr 01
Unknown status
Phase 2
Study of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma Start of enrollment: 2019 Apr 16
Completed
Phase 1
A Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) Start of enrollment: 2022 Feb 23
Terminated
Phase 1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Systemic Therapy Improvements Will Render Locoregional Treatments Obsolete for Patients with Cancer with Liver Metastases.
Satya Das, Jordan Berlin
Hematology/oncology Clinics of North America. 2025-02-01
Executive Summary of the American Radium Society on Appropriate Use Criteria for Nonoperative Management of Rectal Adenocarcinoma: Systematic Review and Guidelines.
Christopher J Anker, Leila T Tchelebi, J Eva Selfridge, Salma K Jabbour, Dmitriy Akselrod
International Journal of Radiation Oncology, Biology, Physics. 2024-11-15
4 citations
Management of Locally Advanced Rectal Cancer: ASCO Guideline.
Aaron J Scott, Erin B Kennedy, Jordan Berlin, Gina Brown, Myriam Chalabi
Journal of Clinical Oncology. 2024-10-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
European Society of Medical Oncology
Member
American Association for Cancer Research - AACR
Member